JW Pharmaceutical Corporation (KRX:001065)
South Korea · Delayed Price · Currency is KRW 29,200
-200 (-0.68%)
At close: Jan 9, 2026
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 626.58 billion as of January 9, 2026. Its market cap has increased by 16.81% in one year.
Market Cap
626.58B
Enterprise Value
612.73B
Revenue
764.21B
Ranking
n/a
PE Ratio
10.81
Stock Price
29,200.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 626.58B, an increase of 645.73%. That is a compound annual growth rate of 9.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 626.58B | 7.12% |
| Dec 30, 2025 | 584.93B | 4.14% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |